BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29700171)

  • 1. Short-hairpin RNA against aberrant
    Patsali P; Papasavva P; Stephanou C; Christou S; Sitarou M; Antoniou MN; Lederer CW; Kleanthous M
    Haematologica; 2018 Sep; 103(9):e419-e423. PubMed ID: 29700171
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by
    Koniali L; Flouri C; Kostopoulou MI; Papaioannou NY; Papasavva PL; Naiisseh B; Stephanou C; Demetriadou A; Sitarou M; Christou S; Antoniou MN; Kleanthous M; Patsali P; Lederer CW
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells.
    Cromer MK; Camarena J; Martin RM; Lesch BJ; Vakulskas CA; Bode NM; Kurgan G; Collingwood MA; Rettig GR; Behlke MA; Lemgart VT; Zhang Y; Goyal A; Zhao F; Ponce E; Srifa W; Bak RO; Uchida N; Majeti R; Sheehan VA; Tisdale JF; Dever DP; Porteus MH
    Nat Med; 2021 Apr; 27(4):677-687. PubMed ID: 33737751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of beta654-thalassemia in mouse model with the knockdown of aberrantly spliced beta-globin mRNA.
    Xie S; Li W; Ren Z; Zhang J; Guo X; Wang S; Huang S; Zeng F; Zeng YT
    J Genet Genomics; 2008 Oct; 35(10):595-601. PubMed ID: 18937916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
    Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
    Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative and Absolute Quantification of Aberrant and Normal Splice Variants in
    Patsali P; Papasavva P; Christou S; Sitarou M; Antoniou MN; Lederer CW; Kleanthous M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells.
    Patsali P; Turchiano G; Papasavva P; Romito M; Loucari CC; Stephanou C; Christou S; Sitarou M; Mussolino C; Cornu TI; Antoniou MN; Lederer CW; Cathomen T; Kleanthous M
    Haematologica; 2019 Nov; 104(11):e497-e501. PubMed ID: 31004018
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia.
    Morianos I; Siapati EK; Pongas G; Vassilopoulos G
    Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.
    Dever DP; Bak RO; Reinisch A; Camarena J; Washington G; Nicolas CE; Pavel-Dinu M; Saxena N; Wilkens AB; Mantri S; Uchida N; Hendel A; Narla A; Majeti R; Weinberg KI; Porteus MH
    Nature; 2016 Nov; 539(7629):384-389. PubMed ID: 27820943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome Editing for the β-Hemoglobinopathies.
    Porteus MH
    Adv Exp Med Biol; 2017; 1013():203-217. PubMed ID: 29127682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.
    Breveglieri G; Mancini I; Bianchi N; Lampronti I; Salvatori F; Fabbri E; Zuccato C; Cosenza LC; Montagner G; Borgatti M; Altruda F; Fagoonee S; Carandina G; Rubini M; Aiello V; Breda L; Rivella S; Gambari R; Finotti A
    Biomed Res Int; 2015; 2015():687635. PubMed ID: 26097845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant AAV2-mediated β-globin expression in human fetal hematopoietic cells from the aborted fetuses with β-thalassemia major.
    Tian J; Wang F; Xue JF; Zhao F; Song LJ; Tan MQ
    Int J Hematol; 2011 Jun; 93(6):691-699. PubMed ID: 21617888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia.
    Xu S; Luk K; Yao Q; Shen AH; Zeng J; Wu Y; Luo HY; Brendel C; Pinello L; Chui DHK; Wolfe SA; Bauer DE
    Blood; 2019 May; 133(21):2255-2262. PubMed ID: 30704988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular characterization of Beta globin gene in thalassemia patients reveals rare and a novel mutations in Pakistani population.
    Yasmeen H; Toma S; Killeen N; Hasnain S; Foroni L
    Eur J Med Genet; 2016 Aug; 59(8):355-62. PubMed ID: 27263053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia.
    Nualkaew T; Sii-Felice K; Giorgi M; McColl B; Gouzil J; Glaser A; Voon HPJ; Tee HY; Grigoriadis G; Svasti S; Fucharoen S; Hongeng S; Leboulch P; Payen E; Vadolas J
    Mol Ther; 2021 Sep; 29(9):2841-2853. PubMed ID: 33940155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
    Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
    Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an in vitro model of β-thalassemia using the CRISPR/Cas9 genome editing system.
    Ajami M; Atashi A; Kaviani S; Kiani J; Soleimani M
    J Cell Biochem; 2020 Feb; 121(2):1420-1430. PubMed ID: 31596028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
    Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
    Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation.
    Gabr H; El Ghamrawy MK; Almaeen AH; Abdelhafiz AS; Hassan AOS; El Sissy MH
    Stem Cell Res Ther; 2020 Sep; 11(1):390. PubMed ID: 32912325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten Years of Routine α- and β-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations.
    Henderson SJ; Timbs AT; McCarthy J; Gallienne AE; Proven M; Rugless MJ; Lopez H; Eglinton J; Dziedzic D; Beardsall M; Khalil MS; Old JM
    Hemoglobin; 2016; 40(2):75-84. PubMed ID: 26635043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.